{"nctId":"NCT00831129","briefTitle":"A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs","startDateStruct":{"date":"2006-09"},"conditions":["Pre-diabetes"],"count":53,"armGroups":[{"label":"Simvastatin + Placebo Rosiglitazone","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Placebo Rosiglitazone","Drug: Simvastatin"]},{"label":"Simvastatin + rosiglitazone","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Rosiglitazone","Drug: Simvastatin"]}],"interventions":[{"name":"Rosiglitazone","otherNames":["Avandia"]},{"name":"Placebo Rosiglitazone","otherNames":["Placebo"]},{"name":"Simvastatin","otherNames":["Zocor"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* 21-75 years\n* Metabolic syndrome (3 of the 5 components)\n* Elevated waist circumference \\>40inches in men, \\>35inches in women\n* Elevated triglycerides \\>150mg/dL\n* Reduced HDL \\<40mg/dL in men, \\<50mg/dL in women\n* Elevated blood pressure \\>130mmHg systolic, \\>85mmHg diastolic\n* Elevated fasting glucose \\>100mg/dL\n\nExclusion Criteria:\n\n* Diabetes mellitus\n* Stage 3 hypertension \\>180mmHg systolic, \\>110mmHg diastolic office blood pressure\n* History of non-diabetic kidney disease\n* Myocardial infarction of unstable angina within the past 6 months\n* History of liver disease\n* History of malignancy\n* History of drug or alcohol abuse\n* Treatment with corticosteroids\n* Pregnancy or lactating women of women of child bearing potential who are not willing to use reliable contraception method during the study","healthyVolunteers":true,"sex":"ALL","minimumAge":"21 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in High-sensitivity C-reactive Protein","description":"change in high-sensitivity C-reactive between baseline and 6 month","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.72","spread":"2.49"},{"groupId":"OG001","value":"-0.61","spread":"1.36"}]}]}]},{"type":"SECONDARY","title":"Change in Urinary Isoprostane","description":"change in urinary isoprostane between baseline and 6 month","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.79","spread":"2.1"},{"groupId":"OG001","value":"-1.09","spread":"1.9"}]}]}]},{"type":"SECONDARY","title":"Change in Malondialdehyde","description":"change in Malondialdehyde between baseline and 6 month","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.27","spread":"2.4"},{"groupId":"OG001","value":"-1.52","spread":"3.0"}]}]}]},{"type":"SECONDARY","title":"Change in Office Systolic Blood Pressure","description":"change in office systolic blood pressure between baseline and 6 month","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-18.24","spread":"12.5"},{"groupId":"OG001","value":"-16.77","spread":"15.2"}]}]}]},{"type":"SECONDARY","title":"Change in Office Diastolic Blood Pressure","description":"change in office diastolic blood pressure between baseline and 6 month","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-9.59","spread":"9.9"},{"groupId":"OG001","value":"-9.46","spread":"8.4"}]}]}]},{"type":"SECONDARY","title":"Change in (Ambulatory Blood Pressure Monitoring) Systolic Blood Pressure","description":"change in (ambulatory blood pressure monitoring) systolic blood pressure between baseline and 6 month","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.41","spread":"3.7"},{"groupId":"OG001","value":"-1.08","spread":"1.2"}]}]}]},{"type":"SECONDARY","title":"Change in (Ambulatory Blood Pressure Monitoring) Diastolic Blood Pressure","description":"change in (ambulatory blood pressure monitoring) diastolic blood pressure between baseline and 6 month","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.88","spread":"0.9"},{"groupId":"OG001","value":"-0.69","spread":"0.6"}]}]}]},{"type":"SECONDARY","title":"Change in Low-density Lipoprotein","description":"change in low-density lipoprotein between baseline and 6 month","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-38.88","spread":"41.2"},{"groupId":"OG001","value":"-28.77","spread":"31.7"}]}]}]},{"type":"SECONDARY","title":"Change in Triglycerides","description":"change in Triglycerides between baseline and 6 month","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-34.32","spread":"22.1"},{"groupId":"OG001","value":"-42.47","spread":"27.3"}]}]}]},{"type":"SECONDARY","title":"Change in High-density Lipoprotein","description":"change in high-density lipoprotein between baseline and 6 month","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.71","spread":"7.9"},{"groupId":"OG001","value":"2.77","spread":"6.7"}]}]}]},{"type":"SECONDARY","title":"Change in Glycosylated Haemoglobin","description":"change in glycosylated haemoglobin between baseline and 6 month","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.12","spread":"0.11"},{"groupId":"OG001","value":"-0.22","spread":"0.07"}]}]}]},{"type":"SECONDARY","title":"Change in Fasting Blood Glucose","description":"change in fasting blood glucose between baseline and 6 month","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.94","spread":"10.9"},{"groupId":"OG001","value":"-4.85","spread":"11.3"}]}]}]},{"type":"SECONDARY","title":"Change in Insulin","description":"change in Insulin between baseline and 6 month","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.59","spread":"1.1"},{"groupId":"OG001","value":"-3.47","spread":"1.8"}]}]}]},{"type":"SECONDARY","title":"Change in Homeostatic Model Assessment for Insulin Resistance","description":"change in homeostatic model assessment for insulin resistance between baseline and 6 month","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.31","spread":"1.4"},{"groupId":"OG001","value":"-2.08","spread":"2.8"}]}]}]},{"type":"SECONDARY","title":"Change in Adiponectin","description":"change in Adiponectin between baseline and 6 month","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.24","spread":"1.3"},{"groupId":"OG001","value":"4.15","spread":"3.9"}]}]}]},{"type":"SECONDARY","title":"Change in Body Mass Index","description":"change in body mass index between baseline and 6 month","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.21","spread":"2.18"},{"groupId":"OG001","value":"0.68","spread":"1.1"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":20},"commonTop":["Nonspecific muscle aches in lower extremities","Joint aches","Upper respiratory symptoms","Nausea Vomiting","Headaches"]}}}